Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.95 USD | +0.12% | -1.06% | +4.90% |
May. 09 | Argus Adjusts Price Target on Hologic to $95 From $89 | MT |
May. 06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
Evolution of the average Target Price on Hologic, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Hologic, Inc.
Argus | |
JPMorgan Chase | |
UBS | |
RBC Capital Markets | |
Citigroup | |
Needham & Co. | |
BofA Securities | |
Morgan Stanley | |
Raymond James | |
Mizuho Securities | |
Wells Fargo Securities | |
Baptista Research | |
Cowen | |
SVB Securities LLC | |
Evercore ISI | |
BTIG | |
Redburn | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- HOLX Stock
- Consensus Hologic, Inc.